Related Experiment Video
Updated: Jul 30, 2026

12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
LPS-nonresponsive variants of mouse B cell lymphoma, 70Z/3: isolation and characterization
Summary
Researchers used a genetic approach to study B lymphocyte differentiation. They identified two types of B cells unresponsive to lipopolysaccharide (LPS), suggesting defects in the differentiation signaling pathway.
Area of Science:
- Immunology
- Cell Biology
- Genetics
Background:
- The murine cell line 70Z/3 mimics pre-B cells, expressing internal immunoglobulin heavy chain (IgM, mu) but lacking light chain (L).
- Activation with B cell mitogen lipopolysaccharide (LPS) normally induces 70Z/3 cells to mature into B lymphocytes, expressing surface IgM and L chain.
Purpose of the Study:
- To investigate the genetic basis of B lymphocyte differentiation using the 70Z/3 cell line.
- To identify mutations affecting the response to lipopolysaccharide (LPS)-induced differentiation.
Main Methods:
- Utilized immunoselection against surface-bound IgM to isolate LPS-uninducible variants of the 70Z/3 cell line.
- Characterized variants by their response to LPS stimulation and assessed for structural defects.
Main Results:
- Two complementation groups of LPS-uninducible variants, designated LPS A and LPS B, were identified.
- LPS A variants (1/1200 frequency) were completely unresponsive to LPS. LPS B variants showed a subset of cells inducible for surface IgM, with induction increasing upon prolonged LPS exposure.
- No structural defects were found in either variant group.
Conclusions:
- LPS A variants likely harbor mutations in genes essential for LPS-mediated signaling or differentiation.
- LPS B variants may possess a defect in the decision-making process for LPS-induced B cell differentiation.
More Related Videos
08:00A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023